Owkin’s Collaboration With Sanofi

McDermott Will & Emery and Latham & Watkins advised Owkin on the deal. Covington & Burling LLP advised Sanofi. Owkin, an artificial intelligence and precision medicine...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Gemspring Capital’s Acquisition of AINS

McDermott Will & Emery represented Gemspring Capital Management in the transaction. Gemspring Capital Management, LLC, a Connecticut-based private equity firm, finalized its majority interest acquisition of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Acticor Biotech’s IPO

McDermott has advised Acticor Biotech on the offering. Acticor Biotech, a clinical stage biopharmaceutical company dedicated to developing a drug for the treatment of cardiovascular emergencies,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Ardian’s Acquisition of Group RG

McDermott Will & Emery advised Ardian on the deal. Ardian completed its acquisition of Group RG from LBO France, alongside the management team and Latour Capital....

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here